Immunohistochemical staining showed a significant reduction in the BrdU incorporation in the epithelial compartment of the mouse tumours in the animals engrafted with FPS tumour and treated with a CXCL8 neutralising antibody compared with FPS IgG controls (Fig. 7A; P < 0.001). This evidence concerns the gene CXCL8 and neoplasm.